Ignite Creation Date:
2024-10-26 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06597929
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-09-11
Brief Title:
Moderate-vigorous Intermittent Physical Activity M-VILPA in Stroke
Sponsor:
None
Organization:
None
Study Overview
Official Title:
The Effectiveness of Moderate-vigorous Intermittent Lifestyle Physical Activity and Health Education to Increase Intense Physical Activity in Stroke Survivors a Pragmatic Randomised Controlled Trial MV-ILPA-stroke
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PA-stroke
Brief Summary:
Stroke is the leading cause of disability in Spain Additionally it is the second leading cause of death in women and the third in both sexes Regular physical activity PA helps prevent and manage stroke It also helps with hypertension maintains a healthy body weight and improves mental health quality of life and well-being PA plays a prominent role in inpatient care after stroke However stroke survivors become more sedentary when discharged from the hospital They have muscle weakness reduced balance and fatigue Consequently PA levels of community-dwelling post-stroke individuals remain lower than their age-matched counterparts Continued PA can help this population maintain and improve physical function and reduce long-term functional limitations and mortality risk
Detailed Description:
Previous studies that performed a comparative analysis of physical activity between individuals with and without stroke have consistently reported that stroke survivors tend to spend less time in moderate to vigorous physical activity The 2021 AHA guideline recommends smaller sessions of PA with suggestions such as 10 minutes of moderate activity 4 times a week or 20 minutes of vigorous activity twice a week This contrasts the weekly physical activity recommendations in 2011 30 minutes of moderate to vigorous 1 to 3 times and 2014 40 minutes of moderate to vigorous 3 to 4 times We hypothesise that older stroke survivors are physically active more frequently but for smaller durations than younger stroke survivors who are physically active for longer durations but less regularly Understanding these subtle changes will not only help to tailor physical activity interventions based on specific recommendations but also help design future recommendations
Moderate-to-vigorous PA could be an adequate approach for stroke survivors as it requires less time to achieve the same benefits as light PA More concretely a new concept called moderate-to-vigorous intermittent lifestyle physical activity MV-ILPA has recently emerged for adults who do not habitually exercise in their leisure time MV-ILPA refers to brief and sporadic bouts of moderate-vigorous intensity PA performed as part of the activities of daily living such as bursts of very fast walking sitting and standing up from a chair or stair climbing MV-ILPA is associated with a substantially lower risk of all-cause cardiovascular disease and cancer mortality However there is no evidence to directly support the potential benefits of MV-ILPA in the elderly post-stroke patients
Moderate-to-vigorous PA could be an adequate approach for stroke survivors as it requires less time to achieve the same benefits as light PA More concretely a new concept called moderate-to-vigorous intermittent lifestyle physical activity MV-ILPA has recently emerged for adults who do not habitually exercise in their leisure time MV-ILPA refers to brief and sporadic bouts of moderate-vigorous intensity PA performed as part of the activities of daily living such as bursts of very fast walking sitting and standing up from a chair or stair climbing MV-ILPA is associated with a substantially lower risk of all-cause cardiovascular disease and cancer mortality However there is no evidence to directly support the potential benefits of MV-ILPA in the elderly post-stroke patients
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None